Search the Newsreel

Valiant Laboratories Q1 Results: Net profit jumps 422% YoY to ₹9.48 cr

Understanding Momentum Shifts in (ORIC)

This article provides an analysis of Oric Pharmaceuticals Inc. (NASDAQ: ORIC), focusing on momentum shifts and potential trading strategies based on AI models. It highlights strong near and mid-term sentiment, identifies compelling upside potential due to the absence of resistance levels, and offers specific …

ORIX Corporation proposed to acquire FleetPartners Group Limited for approximately AUD 810 million.

ORIX Corporation has made a proposal to acquire FleetPartners Group Limited for approximately AUD 810 million. The offer includes a cash consideration of AUD 3.8 per share. The transaction is contingent on various approvals including the target board, regulatory bodies, a due diligence investigation, …

Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Abbott Laboratories (NYSE:ABT) has received a consensus "Moderate Buy" rating from twenty-six brokerages, with an average 12-month price target of $118.17. The company recently exceeded quarterly expectations with adjusted EPS of $1.31 and revenue of $12.59 billion, and announced a quarterly dividend of $0.63 …

Dr. Reddy's Laboratories slides Wednesday, underperforms competitors

Dr. Reddy's Laboratories Ltd. shares fell 0.50% on Wednesday to 1,198.95 Indian rupees, underperforming the broader market as the BSE SENSEX Index dropped 0.24%. The company's stock closed 15.23% below its 52-week high achieved on June 29th.

Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating

Barclays has updated its price target for IDEXX Laboratories (IDXX), lowering it to $710 from the previous $800. Despite this adjustment, the firm has decided to maintain its Overweight rating on the stock. This indicates a continued positive outlook on the company's performance, even …

OESX Technical Analysis & Stock Price Forecast

This article provides a technical analysis and stock price forecast for Orion Energy Systems Inc (OESX). It indicates a "Strong Buy" consensus based on various technical indicators, including moving averages and MACD. However, the Relative Strength Index (RSI) suggests the stock is currently overbought.

IDEXX launches in-clinic cardiac test for cats and dogs

IDEXX Laboratories Inc. has launched the Catalyst proBNP Test, an in-clinic diagnostic tool for heart disease in cats and dogs. This test measures the NT-proBNP biomarker, providing rapid quantitative results to veterinarians for screening, diagnosis, and monitoring of cardiac conditions. The test will be …

Far East Horizon (SEHK:3360) Posts Half Year Results And Interim Dividend, Is The Stock Still Cheap?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Key earnings and dividend announcements for Far East Horizon Far East Horizon (SEHK:3360) recently released half year 2026 results alongside an interim dividend declaration, …

Apollo Sindoori Hotels consolidated net profit declines 55.44% in the June 2026 quarter

JHS Svendgaard Laboratories consolidated net profit rises 2.83% in the June 2026 quarter

IDEXX Laboratories (IDXX) Unveils First Dual Species Cardiac Test For Dogs And Cats

If EPS Growth Is Important To You, Arvee Laboratories (India) (NSE:ARVEE) Presents An Opportunity

Dorian LPG Ltd (LPG) Stock Down 3.2% but Still Overvalued -- GF Score: 85/100

Dorian LPG Ltd's stock (LPG) recently dropped 3.2% to $43.04, yet it is considered overvalued according to GuruFocus's GF Value™ of $41.55. The company boasts a strong GF Score™ of 85/100, driven by high profitability and momentum, but shows weaker growth and recent insider …

¿Puede Abbott Laboratories (ABT) Estar 8% Infravalorada Tras Mejorar Su Previsión Anual?

Bio-Rad (BIO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Ruben ArguetaChief Executive Officer - Norman SchwartzPresident and Chief Operating Officer - Jonathan DiVincenzoExecutive Vice President and Chief Financial Officer - Roop Lakkaraju …

Abbott Laboratories (ABT) schedules NYSE sale of stock from vested awards

Abbott Laboratories (ABT) has filed a Form 144 indicating a planned sale of 5,850 common shares through UBS Financial Services on or after August 11, 2026, on the NYSE. The shares originate from vested restricted stock awards granted on February 27, 2026, totaling 1,960, …

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day

Charles River Laboratories International Inc. (CRL) saw its stock advance by 1.81% to $282.00 on Tuesday, marking its sixth consecutive day of gains. This performance stood out on a generally grim trading day where the S&P 500 Index fell 0.32% and the Dow Jones …

$30k donation made to Northeast Mississippi Habitat for Humanity

The Tennessee Valley Authority (TVA) has donated $30,000 to Northeast Mississippi Habitat for Humanity. This contribution will support the organization's mission to build affordable homes, strengthen communities, and provide opportunities for families to achieve homeownership stability. Both organizations highlighted the importance of such partnerships …

Insider Selling: Charles River Laboratories International (NYSE:CRL) Director Sells $7,901,575.00 in Stock

Charles River Laboratories International Director James Foster sold 28,733 shares of NYSE:CRL stock for approximately $7.9 million at an average price of $275, reducing his direct ownership by 47.63%. This transaction, conducted under a pre-arranged Rule 10b5-1 trading plan, comes amidst generally positive analyst …

Silicon Laboratories (SLAB) Beats Q2 Earnings Estimates

Silicon Laboratories (SLAB) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors

IDEXX Laboratories Inc. (IDXX) stock fell 1.53% on Tuesday, closing at $586.64, despite a general downturn in the stock market. The S&P 500 Index and Dow Jones Industrial Average also saw declines of 0.32% and 0.34%, respectively. The company's stock is now 23.81% below …

Charles River Laboratories (CRL) EVP LaPlume reports bona fide gift of 257 shares

Joseph W. LaPlume, EVP, Corp Strategy & Develop at Charles River Laboratories International, Inc. (CRL), reported a bona fide gift of 257 shares of common stock on August 10, 2026. This transaction was a disposition at a reported per-share price of $0.00, leaving LaPlume …

Charles River (CRL) director James C. Foster exercises options and sells 28,733 shares

Charles River Laboratories International director James C. Foster exercised stock options for 28,733 shares at $179.66 per share and immediately sold them at $275.00 per share on August 10, 2026, pursuant to a Rule 10b5-1 Trading Plan. This transaction resulted in an approximate pre-tax …

Silicon Laboratories (SLAB) Releases Q2 2026 Earnings: Revenue Up 18.3% but Losses Persist

Earnings Flash (SLAB) Silicon Laboratories Inc. Posts Q2 Adjusted EPS $0.71 per Share, vs. FactSet Est of $0.69

Earnings Flash (SLAB) Silicon Laboratories Inc. Reports Q2 Revenue $228.2M, vs. FactSet Est of $228.0M

Silicon Laboratories Inc. (SLAB) reported its Q2 revenue at $228.2 million, surpassing the FactSet estimate of $228.0 million. This financial update indicates a slight beat on revenue expectations for the second quarter. The company also reported Q2 adjusted EPS of $0.71 per share, exceeding …

Silicon Labs (NASDAQ: SLAB) grows Q2 sales as $231-per-share TI merger advances

Silicon Laboratories Inc. reported increased Q2 2026 sales to $228.2 million, up from $192.8 million the previous year, driven by both Industrial & Commercial and Home & Life products, with gross margin improving to 61.6%. Despite revenue growth, the company incurred a net loss …

Silicon Laboratories (NASDAQ:SLAB) Posts Earnings Results, Beats Expectations By $0.02 EPS

Silicon Laboratories (NASDAQ:SLAB) announced its quarterly earnings, surpassing analyst expectations with an EPS of $0.71 against a consensus of $0.69, and revenue of $228.19 million. The stock increased to $218.94, nearing its 52-week high, bringing its market capitalization to approximately $7.22 billion. Despite the …

Silicon Labs Reports Second Quarter 2026 Results

Silicon Labs reported strong financial results for the second quarter of 2026, with revenue reaching $228 million, an 18% increase year-over-year. The company saw significant growth in its Industrial & Commercial and Medical segments, along with improved profitability and a non-GAAP diluted earnings per …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 11, 2026)

This SEC filing (Form 144) for Charles River Laboratories International, Inc. (CRL) details a proposed sale of 6,500 shares of common stock, valued at $1,819,350.00, acquired through the exercise of stock options on August 11, 2026. The transaction was handled by UBS Financial Services, …

Horizon Food Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Orient Press Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Transcript : IFGL Refractories Limited, Q1 2027 Earnings Call, Aug 11, 2026

Morixe Hermanos S.A.C.I. presenta sus resultados del segundo trimestre y del primer semestre de 2026

Mesa Labs Posts Margin Surge, Pays Down $8.7 Million in Debt as New CEO Tackles Delivery Delays

Mesa Laboratories reported a 1% increase in Q1 revenue to $60.1 million, with adjusted operating income surging nearly 20% and gross margin expanding to 64.9% due to cost controls. The company generated $14.7 million in operating cash flow and repaid $8.7 million in debt, …